Alcohol consumption and diabetes risk in the Diabetes Prevention Program

被引:39
|
作者
Crandall, Jill P. [1 ]
Polsky, Sarit [1 ]
Howard, Andrea A. [2 ]
Perreault, Leigh [3 ]
Bray, George A. [4 ]
Barrett-Connor, Elizabeth [5 ]
Brown-Friday, Janet [1 ]
Whittington, Tracy [6 ]
Foo, Sandra [7 ]
Ma, Yong [8 ]
Edelstein, Sharon L. [8 ]
机构
[1] Albert Einstein Coll Med, Bronx, NY 10467 USA
[2] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA
[3] Univ Colorado Denver, Sch Med, Aurora, CO USA
[4] Louisiana State Univ, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA
[5] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA
[6] Johns Hopkins Sch Med, Baltimore, MD USA
[7] St Lukes Roosevelt Hosp, New York, NY 10025 USA
[8] George Washington Univ, Ctr Biostat, Rockville, MD USA
基金
美国国家卫生研究院;
关键词
LIFE-STYLE INTERVENTION; BETA-CELL FUNCTION; INSULIN SENSITIVITY; DRINKING PATTERNS; MELLITUS; WOMEN; MEN; RESISTANCE; SECRETION; METFORMIN;
D O I
10.3945/ajcn.2008.27382
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background: Moderate alcohol consumption is associated with a decreased risk of type 2 diabetes in the general population, but little is known about the effects in individuals at high risk of diabetes. Objectives: The objectives were to determine associations between alcohol consumption and diabetes risk factors and whether alcohol consumption was a predictor of incident diabetes in individuals enrolled in the Diabetes Prevention Program (DPP). Design: DPP participants (n = 3175) had impaired glucose tolerance (2-h glucose: 7.8-11.1 mmol/L), elevated fasting glucose (5.3-7.0 mmol/L), and a body mass index (in kg/m(2)) >= 24. Participants were randomly assigned to placebo, metformin, or lifestyle modification and were followed for a mean of 3.2 y. Alcohol intake was assessed at baseline and year 1 by using a semiquantitative food-frequency questionnaire. Diabetes was diagnosed by annual oral-glucose-tolerance testing and semiannual fasting plasma glucose measurement. Results: Participants who reported higher alcohol consumption tended to be male, older, white, and less obese and to have a higher calorie intake and a higher HDL-cholesterol concentration. Higher alcohol consumption was associated with lower insulin secretion at any level of insulin sensitivity. We found lower incidence rates of diabetes with higher alcohol consumption in the metformin (P < 0.01 for trend) and lifestyle modification (P = 0.02 for trend) groups, which remained significant after adjustment for multiple baseline covariates. No similar association was observed in the placebo group. Conclusions: Despite overall low rates of alcohol consumption, there was a reduced risk of incident diabetes in those who reported modest daily alcohol intake and were assigned to metformin or lifestyle modification. Moderate daily alcohol intake is associated with lower insulin secretion-an effect that warrants further investigation. This trial was registered at clinicaltrials.gov as NCT00038727. Am J Clin Nutr 2009;90:595-601.
引用
收藏
页码:595 / 601
页数:7
相关论文
共 50 条
  • [1] Menopause and risk of diabetes in the Diabetes Prevention Program
    Kim, Catherine
    Edelstein, Sharon L.
    Crandall, Jill P.
    Dabelea, Dana
    Kitabchi, Abbas E.
    Hamman, Richard F.
    Montez, Maria G.
    Perreault, Leigh
    Foulkes, Mary A.
    Barrett-Connor, Elizabeth
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2011, 18 (08): : 857 - 868
  • [2] Metformin for diabetes prevention: insights gained from the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study
    Aroda, Vanita R.
    Knowler, William C.
    Crandall, Jill P.
    Perreault, Leigh
    Edelstein, Sharon L.
    Jeffries, Susan L.
    Molitch, Mark E.
    Pi-Sunyer, Xavier
    Darwin, Christine
    Heckman-Stoddard, Brandy M.
    Temprosa, Marinella
    Kahn, Steven E.
    Nathan, David M.
    Grp, Diabet Prevention Program Res
    DIABETOLOGIA, 2017, 60 (09) : 1601 - 1611
  • [3] Subtypes of gestational diabetes and future risk of pre-diabetes or diabetes
    Retnakaran, Ravi
    Ye, Chang
    Hanley, Anthony J.
    Connelly, Philip W.
    Sermer, Mathew
    Zinman, Bernard
    ECLINICALMEDICINE, 2021, 40
  • [4] Alcohol consumption and risk of pre-diabetes and type 2 diabetes development in a Swedish population
    Cullmann, M.
    Hilding, A.
    Ostenson, C. -G.
    DIABETIC MEDICINE, 2012, 29 (04) : 441 - 452
  • [5] Alcohol Consumption, Diabetes Risk, and Cardiovascular Disease Within Diabetes
    Polsky, Sarit
    Akturk, Halis K.
    CURRENT DIABETES REPORTS, 2017, 17 (12)
  • [6] Statin use and risk of developing diabetes: results from the Diabetes Prevention Program
    Crandall, Jill P.
    Mather, Kieren
    Rajpathak, Swapnil N.
    Goldberg, Ronald B.
    Watson, Karol
    Foo, Sandra
    Ratner, Robert
    Barrett-Connor, Elizabeth
    Temprosa, Marinella
    BMJ OPEN DIABETES RESEARCH & CARE, 2017, 5 (01)
  • [7] Antidepressant Medicine Use and Risk of Developing Diabetes During the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study
    Rubin, Richard R.
    Ma, Yong
    Peyrot, Mark
    Marrero, David G.
    Price, David W.
    Barrett-Connor, Elizabeth
    Knowler, William C.
    DIABETES CARE, 2010, 33 (12) : 2549 - 2551
  • [8] Achievement of Weight Loss and Other Requirements of the Diabetes Prevention and Recognition Program: A National Diabetes Prevention Program Network Based on Nationally Certified Diabetes Self-management Education Programs
    DiBenedetto, Joanna Craver
    Blum, Natalie M.
    O'Brian, Catherine A.
    Kolb, Leslie E.
    Lipman, Ruth D.
    DIABETES EDUCATOR, 2016, 42 (06) : 678 - 685
  • [9] Androgens, Irregular Menses, and Risk of Diabetes and Coronary Artery Calcification in the Diabetes Prevention Program
    Kim, Catherine
    Aroda, Vanita R.
    Goldberg, Ronald B.
    Younes, Naji
    Edelstein, Sharon L.
    Carrion-Petersen, MaryLou
    Ehrmann, David A.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2018, 103 (02) : 486 - 496
  • [10] Failure of monotherapy in clinical practice in patients with type 2 diabetes: The Korean National Diabetes Program
    Jeon, Ja Young
    Lee, Soo Jin
    Lee, Sieun
    Kim, Soo Jin
    Han, Seung Jin
    Kim, Hae Jin
    Kim, Dae Jung
    Kim, Young Seol
    Woo, Jeong Taek
    Ahn, Kyu Jeung
    Nam, Moonsuk
    Baik, Sei Hyun
    Park, Yongsoo
    Lee, Kwan-Woo
    JOURNAL OF DIABETES INVESTIGATION, 2018, 9 (05) : 1144 - 1152